38275-57-9

Basic information

• Product Name: 5-Bromopyrimidine-2-carbonitrile
• Synonyms: 5-BROMO-2-CYANOPYRIMIDINE;5-BROMOPYRIMIDINE-2-CARBONITRILE;5-Bromopyrimidine-2-carbonitrile95%;2-Cyano-5-bromopyrimidine;2-PYRIMIDINECARBONITRILE, 5-BROMO-;5-Bromo-2-pyrimidinecarbonitrile;5-bromo-pyrimidine-2-carb...;5-broMo-pyriMidine-2-carbonitile
• CAS NO: 38275-57-9
• Molecular Formula: C₅H₂BrN₃
• Molecular Weight: 183.99
• Product Categories: Boron, Nitrile, Thio,& TM-Cpds;Heterocycles;Pyrimidine;Cyano;Organohalides;Heterocycle-Pyrimidine series;bromopyrimidine
• Mol File: 38275-57-9.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 317.7 °C at 760 mmHg
• Flash Point: 145.9 °C
• Appearance: White to yellow/Solid
• Density: 1.86g/cm³
• Vapor Pressure: 0.000379mmHg at 25°C
• Refractive Index: 1.617
• Storage Temp.: Room temperature.
• PKA: -4.65±0.22(Predicted)
• Water Solubility: Slightly soluble in water.
• Sensitive: Moisture Sensitive
• CAS DataBase Reference: 5-Bromopyrimidine-2-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromopyrimidine-2-carbonitrile(38275-57-9)
• EPA Substance Registry System: 5-Bromopyrimidine-2-carbonitrile(38275-57-9)

Safety Data

• Hazard Codes: Xi,Xn,N
• Statements: 20/21/22-37/38-41-50
• Safety Statements: 26-36/37-39-61
• RIDADR: 3077
• TSCA: No
• HazardClass: 6.1
• PackingGroup: Ⅲ
• Hazardous Substances Data: 38275-57-9(Hazardous Substances Data)

Usage

Chemical Properties

Light?yellow?crystalline?powder

Uses

5-Bromo-2-cyanopyrimidine is an important raw material and intermediate used in organic synthesis, pharmaceuticals and agrochemicals.

InChI:InChI=1/C5H2BrN3/c6-4-2-8-5(1-7)9-3-4/h2-3H

Upstream product

• 32779-36-5 5-Bromo-2-chloropyrimidine 
• 773837-37-9 sodium cyanide 
• 143-33-9 sodium cyanide 
• 7677-24-9 trimethylsilyl cyanide 
• 36529-69-8 5-bromopyrimidine N-oxide 

Downstream Products

• 1189169-37-6 1-(5-bromopyrimidin-2-yl)ethan-1-one 
• 1454252-62-0 [5-(phenylsulfanyl)pyrimidin-2-yl]methanamine 
• 1454252-63-1 tert-butyl N-[[5-(phenylsulfanyl)pyrimidin-2-yl]methyl]carbamate 
• 1454252-64-2 tert-butyl N-[[5-(benzenesulfonyl)pyrimidin-2-yl]methyl]carbamate 
• 1454252-65-3 [5-(benzenesulfonyl)pyrimidin-2-yl]methanamine 
• 1454250-76-0 imidazo[1,2-a]pyridine-6-carboxylic acid (5-benzenesulfonyl-pyrimidin-2-ylmethyl)-amide 
• 1454252-61-9 5-(phenylsulfanyl)pyrimidin-2-carbonitrile 
• 951658-05-2 5-(4'-bromophenyl)-2-pyrimidinecarbonitrile 
• 951657-88-8 1,4-bis-(2'-cyanopyrimidin-5'-yl)-phenylene 
• 1068975-23-4 (5-bromo-pyrimidine-2-yl)-phenyl-methanone 
• 37131-87-6 5-bromo-2-pyrimidinecarboxylic acid 
• 2503202-14-8 5-(dimethylphosphoryl)pyrimidine-2-carbonitrile 

Relevant articles and documents

Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility

Herein we report the optimization efforts to ameliorate the potent CYP3A4 time-dependent inhibition (TDI) and low aqueous solubility exhibited by a previously identified lead compound from our NAMPT inhibitor program (1, GNE-617). Metabolite identification studies pinpointed the imidazopyridine moiety present in 1 as the likely source of the TDI signal, and replacement with other bicyclic systems was found to reduce or eliminate the TDI finding. A strategy of reducing the number of aromatic rings and/or lowering c Log D7.4 was then employed to significantly improve aqueous solubility. These efforts culminated in the discovery of 42, a compound with no evidence of TDI, improved aqueous solubility, and robust efficacy in tumor xenograft studies.

PYRIDINYL AND PYRIMIDINYL SULFOXIDE AND SULFONE DERIVATIVES

Disclosed are certain pyridinyl and pyrimidinyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds and methods of treatment using such compounds.

2-ALKYNYL-6-PYRIDIN-2-YL-PYRIDAZINONES, 2-ALKYNYL-6-PYRIDIN-2-YL-DIHYDROPYRIDAZINONES, 2-ALKYNYL-6-PYRIMIDIN-2-YL-PYRIDAZINONES AND 2-ALKYNYL-6-PYRIMIDIN-2-YL-DIHYDROPYRIDAZINONES AND THEIR USE AS FUNGICIDES

This invention relates to certain novel 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and to the use of these compounds for control of fungal pathogens of plants and mammals.